About Us

Company Profile

LeadArt Biotechnologies Inc., founded in 2017. LeadArt is the first biotechnology company in China and one of the few in the world that has mastered breakthrough chemical proteomics technology. The company also has mature biotechnology automation equipment development and proven productization capabilities. Powered with state-of-art biotechnology and advanced automation technology, LeadArt is building the largest and leading live cell target-probe database in the world and aspired to expand the drug target space and speed up drug discovery.

Dr. Feng Ni
Co-Founder, Chief Executive Officer
Chemoproteomics and Medicinal Chemistry expert with 15+ years of experience B.S. Chemistry, Xiamen University Ph.D. Organic Chemistry, Xiamen University 2010-2017 Senior Scientist, University of Southern California 2017-2023 Anzhong Chair Professor, the Institute of New Drug Technology, Ningbo University
Dr. Yufeng Zhao
Co-Founder, Board Director
Member of the Chinese Academy of Sciences, More than 30 years of experience in chemical biology research and drug discovery, Dean of the Institute of New Drug Technology, Ningbo University, Professors of Tsinghua University, Xiamen University, Zhengzhou University
JIe Yan
Co-Founder, Chief Operating Officer
14 years + of drug development experiences in the biopharma industry including Amgen and Lexicon Pharmaceuticals in the USA, Co-founder of BioSpark Group in the USA. MS of Iowa State University, Candidate of Doctor of Engineering of Tsinghua University
Frank Ebetino
Drug Development Expert
President of BioVinc USA, former director of the Procter & Gamble's drug research and development department in US, with complete drug development process experience, world authority in phosphorus chemistry
Xi Ning
Expert In Medical Chemistry
Chief Scientific Officer of Guangdong Dongyangguang Pharmaceutical, National Distinguished Expert, Professor of Ningbo University, Former Senior Scientist of the Medicinal Chemistry Department of Amgen
Chen Yuzong
Expert In Chemical Informatics /AI
Professor of Singapore National Unversity, Computational Biology, Computer Aided Drug Design and Bioinformatics Authority
History
Established research and Development and business center in Boston, USA
2022-06
Established the automation production center in Cixi, China
2022-08
Completed the Pre-A round of financing
2022-08
Major Science and Technology Breakthrough Award, Ningbo, China
2021-09
Acquired Keyone Biomedical and established automation team
2020-10
Moved in to LeadArt R&D headquarter
2020-11
Angel round financing
2018-05
Shanglin Elite Entrepreneurship Award
2018-07
Ningbo 3315 Entrepreneurship Award
2018-09
Established LeadArt Technology in USA
2017-04-01
Established Ningbo LeadArt Biotechnology Co Ltd
2017-06-03
Strategic Partners
Collaborators

LeadArt is a leading chemoproteomics and automation platform, and we have established multiple business and collaborations with universities, research institutes, biotech, biopharma, and medical companies.